Results 271 to 280 of about 173,599 (327)
Some of the next articles are maybe not open access.

Treatment of lupus nephritis: consensus, evidence and perspectives

Nature Reviews Rheumatology, 2023
Chi Chiu Mok   +2 more
exaly   +2 more sources

Lupus Nephritis

The American Journal of the Medical Sciences, 2009
Lupus nephritis (LN) is one of the common manifestations of systemic lupus erythematosus. Kidney biopsy remains a mainstay of LN diagnosis, which is usually prompted by abnormal urinary sediment, proteinuria, or elevated creatinine. New International Society of Nephrology/Renal Pathology Society classification of LN tends to remove some of the ...
Sandeep Singh   +2 more
openaire   +2 more sources

Lupus Nephritis

Pediatric Clinics of North America, 2019
Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease ...
Scott E, Wenderfer, Karen W, Eldin
openaire   +2 more sources

Lupus Nephritis

Seminars in Nephrology, 2006
Lupus nephritis is one of the more serious manifestations of the systemic autoimmune disease, systemic lupus erythematosus, and is associated with considerable morbidity and even mortality. Treatment remains problematic, particularly in terms of controlling the underlying disease process while at the same time preventing unacceptable side effects of ...
Neerja, Agrawal   +2 more
openaire   +2 more sources

Phenacetin nephritis

Urology, 1975
Prolonged ingestion of mixed analgesics containing phenacetin has been associated significantly with the development of a chronic interstitial nephritis frequently associated with papillary necrosis. This disease is frequently underdiagnosed. If an adequate history of headache and/or backache (of which most of these patients complain) is not taken, the
openaire   +2 more sources

Home - About - Disclaimer - Privacy